Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.02
NYSE:HCA's Cash to Debt is ranked lower than
93% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 0.32 vs. NYSE:HCA: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:HCA' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.02
Equity to Asset -0.23
NYSE:HCA's Equity to Asset is ranked lower than
97% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. NYSE:HCA: -0.23 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:HCA' s Equity to Asset Range Over the Past 10 Years
Min: -0.5  Med: -0.01 Max: 0.42
Current: -0.23
-0.5
0.42
Interest Coverage 3.64
NYSE:HCA's Interest Coverage is ranked lower than
71% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 7.01 vs. NYSE:HCA: 3.64 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.32  Med: 2.13 Max: 3.64
Current: 3.64
1.32
3.64
F-Score: 7
Z-Score: 2.05
M-Score: -2.92
WACC vs ROIC
3.28%
18.41%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.93
NYSE:HCA's Operating margin (%) is ranked higher than
77% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 6.81 vs. NYSE:HCA: 14.93 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:HCA' s Operating margin (%) Range Over the Past 10 Years
Min: 8.62  Med: 13 Max: 15.86
Current: 14.93
8.62
15.86
Net-margin (%) 6.21
NYSE:HCA's Net-margin (%) is ranked higher than
60% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. NYSE:HCA: 6.21 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:HCA' s Net-margin (%) Range Over the Past 10 Years
Min: 2.37  Med: 4.43 Max: 7.58
Current: 6.21
2.37
7.58
ROA (%) 7.79
NYSE:HCA's ROA (%) is ranked higher than
70% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. NYSE:HCA: 7.79 )
Ranked among companies with meaningful ROA (%) only.
NYSE:HCA' s ROA (%) Range Over the Past 10 Years
Min: 2.79  Med: 5.25 Max: 9.71
Current: 7.79
2.79
9.71
ROC (Joel Greenblatt) (%) 32.23
NYSE:HCA's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 18.74 vs. NYSE:HCA: 32.23 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:HCA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 19.55  Med: 30.17 Max: 37.66
Current: 32.23
19.55
37.66
Revenue Growth (3Y)(%) 9.00
NYSE:HCA's Revenue Growth (3Y)(%) is ranked higher than
55% of the 181 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. NYSE:HCA: 9.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:HCA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.8  Med: 7.7 Max: 24.3
Current: 9
-7.8
24.3
EBITDA Growth (3Y)(%) 8.30
NYSE:HCA's EBITDA Growth (3Y)(%) is ranked higher than
55% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 7.40 vs. NYSE:HCA: 8.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:HCA' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -10  Med: 8.3 Max: 39.4
Current: 8.3
-10
39.4
EPS Growth (3Y)(%) 12.70
NYSE:HCA's EPS Growth (3Y)(%) is ranked higher than
63% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. NYSE:HCA: 12.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:HCA' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 6.9 Max: 88.4
Current: 12.7
0
88.4
» NYSE:HCA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

HCA Guru Trades in Q4 2015

Richard Perry 3,063,000 sh (New)
First Pacific Advisors 49,770 sh (New)
Steven Cohen 109,300 sh (New)
Louis Moore Bacon 130,000 sh (New)
George Soros 79,247 sh (New)
Joel Greenblatt 247,339 sh (New)
Larry Robbins 14,300,549 sh (+159.38%)
David Tepper 4,537,063 sh (+27.68%)
Paul Tudor Jones 9,619 sh (+23.32%)
Vanguard Health Care Fund 11,911,153 sh (+16.96%)
Mario Gabelli 27,800 sh (+2.11%)
Samuel Isaly 1,220,500 sh (unchged)
John Paulson Sold Out
Pioneer Investments Sold Out
John Hussman Sold Out
David Dreman 22,684 sh (-12.08%)
Jim Simons 262,500 sh (-49.17%)
» More
Q1 2016

HCA Guru Trades in Q1 2016

Jeremy Grantham 5,500 sh (New)
Lee Ainslie 369,220 sh (New)
Pioneer Investments 90,037 sh (New)
Joel Greenblatt 622,232 sh (+151.57%)
Steven Cohen 247,800 sh (+126.72%)
Mario Gabelli 50,400 sh (+81.29%)
David Dreman 25,171 sh (+10.96%)
Larry Robbins 14,675,592 sh (+2.62%)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
First Pacific Advisors Sold Out
Paul Tudor Jones Sold Out
George Soros Sold Out
Vanguard Health Care Fund 11,682,053 sh (-1.92%)
Richard Perry 2,768,000 sh (-9.63%)
David Tepper 3,173,423 sh (-30.06%)
Samuel Isaly 1,107,100 sh (-9.29%)
» More
Q2 2016

HCA Guru Trades in Q2 2016

John Hussman 100,000 sh (New)
Andreas Halvorsen 1,089,482 sh (New)
Jim Simons 574,500 sh (New)
Paul Tudor Jones 22,420 sh (New)
Joel Greenblatt 916,670 sh (+47.32%)
Pioneer Investments 90,948 sh (+1.01%)
Mario Gabelli 50,400 sh (unchged)
Vanguard Health Care Fund 11,682,053 sh (unchged)
Steven Cohen Sold Out
Richard Perry Sold Out
Lee Ainslie Sold Out
David Dreman 25,075 sh (-0.38%)
Larry Robbins 14,586,992 sh (-0.60%)
Jeremy Grantham 3,900 sh (-29.09%)
David Tepper 1,216,940 sh (-61.65%)
Samuel Isaly 709,300 sh (-35.93%)
» More
Q3 2016

HCA Guru Trades in Q3 2016

Steve Mandel 1,669,543 sh (New)
Glenn Greenberg 2,498,550 sh (New)
John Paulson 162,500 sh (New)
Jeremy Grantham 4,400 sh (+12.82%)
Larry Robbins 15,988,990 sh (+9.61%)
David Tepper 1,236,940 sh (+1.64%)
Mario Gabelli 50,400 sh (unchged)
Vanguard Health Care Fund 11,682,053 sh (unchged)
Paul Tudor Jones Sold Out
Pioneer Investments Sold Out
Andreas Halvorsen Sold Out
John Hussman Sold Out
David Dreman 24,263 sh (-3.24%)
Joel Greenblatt 379,392 sh (-58.61%)
Jim Simons 45,100 sh (-92.15%)
Samuel Isaly 304,824 sh (-57.02%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:FMS, OTCPK:FSNUY, NYSE:DVA, NYSE:UHS, OTCPK:RMSYF, OTCPK:SKHCY, NYSE:MD, NAS:WOOF, NYSE:HLS, NAS:AMSG, NAS:ACHC, NYSE:CHE, OTCPK:LTGHY, NAS:LPNT, NAS:SCAI, NYSE:SEM, NYSE:THC, NYSE:AMN, NAS:AMED, NAS:PAHC » details
Traded in other countries:2BH.Germany,
HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

HCA Holdings Inc was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. It is a health care services company in the United States. It operates 168 hospitals, comprised of 164 general, acute care hospitals; three psychiatric hospitals; and one rehabilitation hospital. In addition, it operates 116 freestanding surgery centers. Its facilities are located in 20 states and England. Its general, acute care hospitals typically provide services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide mental health care services through inpatient, partial hospitalization and outpatient settings. The Company is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Some competing facilities are physician-owned or are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. It also faces competition from specialty hospitals and from both its own and unaffiliated freestanding ASCs for market share in certain high margin services.

Ratios

vs
industry
vs
history
P/E(ttm) 11.07
HCA's P/E(ttm) is ranked higher than
89% of the 245 Companies
in the Global Medical Care industry.

( Industry Median: 25.71 vs. HCA: 11.07 )
Ranked among companies with meaningful P/E(ttm) only.
HCA' s P/E(ttm) Range Over the Past 10 Years
Min: 4.08  Med: 13.75 Max: 19.67
Current: 11.07
4.08
19.67
Forward P/E 10.13
HCA's Forward P/E is ranked higher than
90% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 18.15 vs. HCA: 10.13 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 11.07
HCA's PE(NRI) is ranked higher than
89% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 25.75 vs. HCA: 11.07 )
Ranked among companies with meaningful PE(NRI) only.
HCA' s PE(NRI) Range Over the Past 10 Years
Min: 4.08  Med: 13.75 Max: 19.67
Current: 11.07
4.08
19.67
Price/Owner Earnings (ttm) 9.16
HCA's Price/Owner Earnings (ttm) is ranked higher than
85% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. HCA: 9.16 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HCA' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 5.84  Med: 11.22 Max: 60.9
Current: 9.16
5.84
60.9
P/S 0.70
HCA's P/S is ranked higher than
77% of the 281 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. HCA: 0.70 )
Ranked among companies with meaningful P/S only.
HCA' s P/S Range Over the Past 10 Years
Min: 0.31  Med: 0.65 Max: 1.07
Current: 0.7
0.31
1.07
PFCF 10.14
HCA's PFCF is ranked higher than
87% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 23.98 vs. HCA: 10.14 )
Ranked among companies with meaningful PFCF only.
HCA' s PFCF Range Over the Past 10 Years
Min: 4.19  Med: 11.52 Max: 17.22
Current: 10.14
4.19
17.22
POCF 5.23
HCA's POCF is ranked higher than
92% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 14.06 vs. HCA: 5.23 )
Ranked among companies with meaningful POCF only.
HCA' s POCF Range Over the Past 10 Years
Min: 2.58  Med: 5.72 Max: 8.53
Current: 5.23
2.58
8.53
EV-to-EBIT 9.86
HCA's EV-to-EBIT is ranked higher than
89% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 19.73 vs. HCA: 9.86 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.7 Max: 12.6
Current: 9.86
6.3
12.6
EV-to-EBITDA 7.41
HCA's EV-to-EBITDA is ranked higher than
88% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 14.47 vs. HCA: 7.41 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.9 Max: 9.4
Current: 7.41
5
9.4
PEG 2.17
HCA's PEG is ranked higher than
59% of the 81 Companies
in the Global Medical Care industry.

( Industry Median: 2.66 vs. HCA: 2.17 )
Ranked among companies with meaningful PEG only.
HCA' s PEG Range Over the Past 10 Years
Min: 0.68  Med: 2.25 Max: 6.07
Current: 2.17
0.68
6.07
Shiller P/E 15.46
HCA's Shiller P/E is ranked higher than
82% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 27.79 vs. HCA: 15.46 )
Ranked among companies with meaningful Shiller P/E only.
HCA' s Shiller P/E Range Over the Past 10 Years
Min: 6.14  Med: 12.81 Max: 22.97
Current: 15.46
6.14
22.97
Current Ratio 1.72
HCA's Current Ratio is ranked higher than
65% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. HCA: 1.72 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 0.81  Med: 1.51 Max: 1.9
Current: 1.72
0.81
1.9
Quick Ratio 1.42
HCA's Quick Ratio is ranked higher than
61% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. HCA: 1.42 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.33 Max: 1.68
Current: 1.42
0.71
1.68
Days Inventory 77.28
HCA's Days Inventory is ranked lower than
85% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 18.12 vs. HCA: 77.28 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 54.26  Med: 65.41 Max: 77.28
Current: 77.28
54.26
77.28
Days Sales Outstanding 48.87
HCA's Days Sales Outstanding is ranked lower than
59% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 42.08 vs. HCA: 48.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 52.29 Max: 56.3
Current: 48.87
44.84
56.3
Days Payable 104.41
HCA's Days Payable is ranked higher than
77% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 38.52 vs. HCA: 104.41 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 104.41  Med: 112.98 Max: 119.5
Current: 104.41
104.41
119.5

Buy Back

vs
industry
vs
history
Yield on cost (5-Year) 0.30
HCA's Yield on cost (5-Year) is ranked lower than
95% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 2.27 vs. HCA: 0.30 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HCA' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.3
3-Year Average Share Buyback Ratio 3.50
HCA's 3-Year Average Share Buyback Ratio is ranked higher than
95% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. HCA: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.1  Med: 2.9 Max: 12
Current: 3.5
-4.1
12

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.42
HCA's Price/Projected FCF is ranked higher than
64% of the 115 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. HCA: 1.42 )
Ranked among companies with meaningful Price/Projected FCF only.
HCA' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.42  Med: 3.84 Max: 29.58
Current: 1.42
1.42
29.58
Price/DCF (Earnings Based) 1.04
HCA's Price/DCF (Earnings Based) is ranked higher than
75% of the 32 Companies
in the Global Medical Care industry.

( Industry Median: 1.63 vs. HCA: 1.04 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.07
HCA's Price/Median PS Value is ranked lower than
59% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 1.00 vs. HCA: 1.07 )
Ranked among companies with meaningful Price/Median PS Value only.
HCA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.52  Med: 0.99 Max: 1.6
Current: 1.07
0.52
1.6
Price/Peter Lynch Fair Value 1.59
HCA's Price/Peter Lynch Fair Value is ranked higher than
65% of the 57 Companies
in the Global Medical Care industry.

( Industry Median: 1.97 vs. HCA: 1.59 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HCA' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.77  Med: 2.08 Max: 3.67
Current: 1.59
0.77
3.67
Earnings Yield (Greenblatt) (%) 10.12
HCA's Earnings Yield (Greenblatt) (%) is ranked higher than
92% of the 295 Companies
in the Global Medical Care industry.

( Industry Median: 4.17 vs. HCA: 10.12 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HCA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 8  Med: 9.3 Max: 16
Current: 10.12
8
16
Forward Rate of Return (Yacktman) (%) 14.24
HCA's Forward Rate of Return (Yacktman) (%) is ranked higher than
65% of the 110 Companies
in the Global Medical Care industry.

( Industry Median: 10.28 vs. HCA: 14.24 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HCA' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9  Med: 13.2 Max: 17.6
Current: 14.24
9
17.6

More Statistics

Revenue (TTM) (Mil) $41,098
EPS (TTM) $ 6.32
Beta0.05
Short Percentage of Float4.08%
52-Week Range $60.07 - 83.69
Shares Outstanding (Mil)374.69

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 43,148 45,358 47,966
EPS ($) 6.57 7.00 7.85
EPS w/o NRI ($) 6.57 7.00 7.85
EPS Growth Rate
(3Y to 5Y Estimate)
11.95%
Dividends Per Share ($)
» More Articles for NYSE:HCA

Headlines

Articles On GuruFocus.com
Dr. Michael Burry of 'The Big Short' Buys Coty and Further Slims Portfolio Dec 01 2016 
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
What to Buy Now That Donald Trump Is President-elect Nov 11 2016 
David Tepper Exits Facebook, Boosts Allergan Aug 31 2016 
The Big 3: Larry Robbins' Top 2nd-Quarter Buys Aug 16 2016 
John Hussman Buys Infosys, Southern Aug 12 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
The “Bribing the Purchasing Agent Model" - Part I Jul 11 2016 
Richard Perry Trims Time Warner, AIG Jun 20 2016 

More From Other Websites
Tommy Frist Jr., Milton Johnson on hand as HCA opens new North Gulch office tower (with slideshow)... Dec 02 2016
[video]Unemployment Tumbles in November, Keeping Fed on Track for Rate Rise Dec 02 2016
Dr. Michael Burry of 'The Big Short' Buys Only One Stock as He Further Cuts Portfolio Dec 01 2016
The Big Short’s Michael Burry Reveals His New Stock Picks Nov 30 2016
What Smart Money Thinks about HCA Holdings Inc (HCA)? Nov 25 2016
HCA HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Nov 16 2016
HCA Announces Promotion of Sam Hazen to President and Chief Operating Officer Nov 16 2016
HCA Holdings Announces Share Repurchase Plan Worth $2B Nov 15 2016
Thermo Fisher Scientific Inc. (TMO), HCA Holdings Inc (HCA) & Two More: Should You Follow Cryder... Nov 15 2016
HCA HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 15 2016
HCA Board Authorizes Additional $2 Billion Share Repurchase Program Nov 14 2016
HCA Board Authorizes Additional $2 Billion Share Repurchase Program Nov 14 2016
A Pair Trade In U.S. Healthcare: Bullish on Centene, Neutral On Aetna Nov 14 2016
Unusual activity: HCA & AKS Nov 14 2016
What to Buy Now That Donald Trump Is President-Elect Nov 11 2016
Bain & Co. Weighs in on the Coding of Hospital Stocks as Obamacare Threatened Under Trump Nov 11 2016
HCA Holdings, Inc. breached its 50 day moving average in a Bearish Manner : HCA-US : November 11,... Nov 11 2016
HCA HOLDINGS, INC. Financials Nov 10 2016
ETF’s with exposure to HCA Holdings, Inc. : November 10, 2016 Nov 10 2016
Trump Win Sends Hospital Shares Into Cardiac Arrest; Drug Wholesalers Rise Nov 09 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)